Litigation
Moderna Therapeutics, Inc. v. Arbutus Biopharma Corp. et al.
closed; claims unpatentableIPR2018-00680
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2018-02-21
- Terminated
- 2019-09-10
Patents at issue (1)
Plaintiffs (1)
Defendants (2)
Summary
Moderna Therapeutics petitioned for inter partes review of all claims 1-22 of US 9,404,127. The PTAB issued a final written decision holding all challenged claims unpatentable as inherently anticipated by U.S. Patent No. 8,058,069.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).